Tag: apricus biosciences
January 25, 2019
Ligand Partner Seelos Therapeutics Becomes a Public Company
Ligand Pharmaceuticals (NASDAQ:LGND) partner Seelos Therapeutics (NASDAQ:SEEL) announced that it has closed a reverse merger with Apricus Biosciences. As quoted in... January 24, 2019
Seelos Therapeutics Announces Successful Completion of its Merger with Apricus Biosciences
Seelos Therapeutics (Nasdaq:SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical...
July 30, 2018
Apricus Biosciences and Seelos Therapeutics Announce Merger
Once the merger is completed, the merged company will be called Seelos Therapeutics and will begin trading on the NASDAQ... July 30, 2018